Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Primary Myelofibrosis 13Myeloproliferative Disorders 10Polycythemia Vera 9Leukemia, Myeloid, Acute 9Myelodysplastic Syndromes 6Graft vs Host Disease 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia 5Thrombocythemia, Essential 4Hematologic Neoplasms 4Breast Neoplasms 4Myelodysplastic-Myeloproliferative Diseases 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Recurrence 2Pancreatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Lymphoma 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Monocytic, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2

Interventions

fludarabine phosphate 10Tacrolimus 10Cyclophosphamide 10Busulfan 10Peripheral Blood Stem Cell Transplantation 7Methotrexate 7Antilymphocyte Serum 7Mycophenolic Acid 5Whole-Body Irradiation 4Methylprednisolone 4Etoposide 4thymoglobulin 3Rituximab 3Radiotherapy 3Melphalan 3Cyclosporine 3Sirolimus 2Prednisone 2Filgrastim 2Cytarabine 2Cord Blood Stem Cell Transplantation 2Carmustine 2Alemtuzumab 2ruxolitinib 1merphos 1gamma-Globulins 1fludarabine 1fedratinib 1etoposide phosphate 1carmustine, poliferprosan 20 drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Neutrophilic, Chronic × ruxolitinib × Clear all
NCT02092324 2020-11-16

Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

OHSU Knight Cancer Institute

Phase 2 Completed
51 enrolled 25 charts
Other hematologic neoplasm

Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡